Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
Background: Mitochondrial dysfunction has been identified as a pathophysiological hallmark of disease onset and progression in patients with Parkinsonian disorders. Besides the overall emergence of gene therapies in treating these patients, this highly relevant molecular concept has not yet been def...
Guardado en:
Autores principales: | Jannik Prasuhn, Norbert Brüggemann |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf8e89f6e60a4c4384145660bf062bf6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gene Therapies for Monogenic Autism Spectrum Disorders
por: Wout Weuring, et al.
Publicado: (2021) -
Applications of CRISPR-Cas Technologies to Proteomics
por: Georgii Dolgalev, et al.
Publicado: (2021) -
Association of GAK rs1564282 With Susceptibility to Parkinson’s Disease in Chinese Populations
por: He Li, et al.
Publicado: (2021) -
Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes
por: Amandine Billaud, et al.
Publicado: (2021) -
Comparative Analysis of Complete Chloroplast Genomes of 13 Species in Epilobium, Circaea, and Chamaenerion and Insights Into Phylogenetic Relationships of Onagraceae
por: Yike Luo, et al.
Publicado: (2021)